In a mouse model of atherosclerosis, pharmacological inhibition of SphKs by a non-selective SphK inhibitor reduced plasma S1P concentration and exhibited both atherogenic and anti-atherogenic properties20. The gene discussed is SPHK1; the disease is atherosclerosis.